Melanie Janning

2.0k total citations
33 papers, 746 citations indexed

About

Melanie Janning is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Melanie Janning has authored 33 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Melanie Janning's work include Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (6 papers) and Angiogenesis and VEGF in Cancer (4 papers). Melanie Janning is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (6 papers) and Angiogenesis and VEGF in Cancer (4 papers). Melanie Janning collaborates with scholars based in Germany, United States and Norway. Melanie Janning's co-authors include Sonja Loges, Isabel Ben‐Batalla, Klaus Pantel, Walter Fiedler, Gunhild von Amsberg, Sabine Riethdorf, Harriet Wikman, Volkmar Müller, Tobias M. Gorges and Carsten Bokemeyer and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Melanie Janning

30 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Janning Germany 14 320 266 208 122 122 33 746
Antreas Hindoyan United States 11 365 1.1× 409 1.5× 128 0.6× 93 0.8× 114 0.9× 24 767
Alice Agliano Spain 12 429 1.3× 431 1.6× 246 1.2× 72 0.6× 100 0.8× 16 810
Caner Saygin United States 10 337 1.1× 426 1.6× 181 0.9× 66 0.5× 79 0.6× 27 767
Andreas Enns Germany 9 289 0.9× 506 1.9× 129 0.6× 59 0.5× 137 1.1× 9 889
Umut H. Toprak Germany 9 223 0.7× 408 1.5× 216 1.0× 73 0.6× 50 0.4× 13 733
David Killock United States 13 344 1.1× 345 1.3× 146 0.7× 151 1.2× 214 1.8× 211 879
Natalia Baran United States 15 153 0.5× 380 1.4× 204 1.0× 50 0.4× 101 0.8× 62 679
Cristina Nieto‐Jiménez Spain 16 464 1.4× 456 1.7× 137 0.7× 139 1.1× 181 1.5× 40 942
Erica T. Goddard United States 12 420 1.3× 228 0.9× 195 0.9× 76 0.6× 120 1.0× 14 706
W Zhang United States 13 437 1.4× 550 2.1× 259 1.2× 65 0.5× 225 1.8× 19 1.0k

Countries citing papers authored by Melanie Janning

Since Specialization
Citations

This map shows the geographic impact of Melanie Janning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Janning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Janning more than expected).

Fields of papers citing papers by Melanie Janning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Janning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Janning. The network helps show where Melanie Janning may publish in the future.

Co-authorship network of co-authors of Melanie Janning

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Janning. A scholar is included among the top collaborators of Melanie Janning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Janning. Melanie Janning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janning, Melanie, et al.. (2025). Aktuelle Entwicklungen zu Liquid Biopsy beim Lungenkarzinom. 28(1-2). 10–14.
2.
3.
Loges, Sonja, et al.. (2024). Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations. memo - Magazine of European Medical Oncology. 17(2). 117–122. 1 indexed citations
4.
Leest, Paul van der, Melanie Janning, Sonja Loges, et al.. (2023). Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients. International Journal of Molecular Sciences. 24(17). 13390–13390. 8 indexed citations
5.
6.
Boch, Tobias, Jens Köhler, Melanie Janning, & Sonja Loges. (2022). Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives. Cancer Biology and Medicine. 19(11). 1543–1564. 21 indexed citations
7.
Boch, Tobias, Nikolaj Frost, Tobias R. Overbeck, et al.. (2021). Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery. Lung Cancer. 164. 46–51. 8 indexed citations
8.
Koch, Claudia, Simon A. Joosse, Melanie Janning, et al.. (2020). Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients. Cancers. 12(2). 442–442. 25 indexed citations
9.
Ben‐Batalla, Isabel, et al.. (2020). Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer. Frontiers in Immunology. 11. 1184–1184. 88 indexed citations
10.
Bergmann, Sonja, Gunhild von Amsberg, Melanie Janning, et al.. (2019). Abstract 2219: Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma of the bladder. Cancer Research. 79(13_Supplement). 2219–2219. 1 indexed citations
11.
Janning, Melanie & Sonja Loges. (2018). Anti-Angiogenics: Their Value in Lung Cancer Therapy. Oncology Research and Treatment. 41(4). 172–180. 29 indexed citations
12.
13.
Wroblewski, Mark, Isabel Ben‐Batalla, Karen Legler, et al.. (2017). Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. Nature Communications. 8(1). 269–269. 66 indexed citations
14.
Wroblewski, Mark, Janna-Lisa Velthaus, Volkmar Müller, et al.. (2017). Effect of mast cells on efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme b.. Journal of Clinical Oncology. 35(15_suppl). 11522–11522. 1 indexed citations
15.
Parveen, Zahida, Melanie Janning, Julia Quidde, et al.. (2016). A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells. International Journal of Cancer. 138(12). 2894–2904. 152 indexed citations
16.
Simister, Philip C., Melanie Janning, Joerg Kumbrink, et al.. (2015). Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3). Journal of Biological Chemistry. 290(42). 25275–25292. 32 indexed citations
17.
Ben‐Batalla, Isabel, Mark Wroblewski, Jonas Waizenegger, et al.. (2015). Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget. 6(8). 6341–6358. 30 indexed citations
18.
Janning, Melanie, Katharina Holstein, Brigitte Spath, et al.. (2013). Relevant bleeding diathesis due to acquired factor XIII deficiency. Hämostaseologie. 33(S 01). S50–S54. 12 indexed citations
19.
20.
Wu, Zhixiang, Jessica Doondeea, Amin Moghaddas Gholami, et al.. (2011). Quantitative Chemical Proteomics Reveals New Potential Drug Targets in Head and Neck Cancer. Molecular & Cellular Proteomics. 10(12). M111.011635–M111.011635. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antreas Hindoyan Breakdown of academic impact, for papers by Alice Agliano Breakdown of academic impact, for papers by Caner Saygin Breakdown of academic impact, for papers by Andreas Enns Breakdown of academic impact, for papers by Umut H. Toprak Breakdown of academic impact, for papers by David Killock Breakdown of academic impact, for papers by Natalia Baran Breakdown of academic impact, for papers by Cristina Nieto‐Jiménez Breakdown of academic impact, for papers by Erica T. Goddard Breakdown of academic impact, for papers by W Zhang
Rankless by CCL
2026